WGS
HealthcareGeneDx Holdings Corp.
$131.50
$-0.80 (-0.60%)
Jan 5, 2026
Price History (1Y)
Analysis
GeneDx Holdings Corp. operates in the healthcare sector within the diagnostics and research industry. With a market capitalization of $3.80B, the company has substantial scale, alongside a workforce of 1000 employees. Financially, GeneDx Holdings Corp. reports a gross margin of 69.6%, but operating and profit margins are negative at -2.8% and 0.5%, respectively. The company's returns on equity and assets are 0.8% and 1.6%, respectively. Its balance sheet shows $113.16M in debt and $155.08M in cash, resulting in a current ratio of 2.71. The company's valuation metrics include a P/E ratio (TTM) of 1195.45 and forward P/E of 315.24. Revenue growth has been substantial at 51.9% year-over-year, but the earnings growth rate is not available.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.
Visit website →Key Statistics
- Market Cap
- $3.80B
- P/E Ratio
- 1195.45
- 52-Week High
- $170.87
- 52-Week Low
- $55.17
- Avg Volume
- 491.53K
- Beta
- 2.07
Company Info
- Industry
- Diagnostics & Research
- Exchange
- NMS
- Country
- United States
- Employees
- 1,000